NON-SMALL CELL EA5181

Study #EA5181

Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresected Stage 3 NSCLC

Back To Clinical Trials